Harpoon Therapeutics

Harpoon Therapeutics

Harpoon Therapeutics

Harpoon Therapeutics is an immunooncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases.
Raised
$70M
Follow us
Alexa global traffic share
Latest funding
$70,000,000
Venture capital (Series C) - 2018
MPM Capital OrbiMed Lilly Asia Ventures +3
Team Size
1–10
Employees
MedCity News

Harpoon Therapeutics files for $86.25M IPO

$70,000,000 Venture capital (Series C)
PE HUB , FinSMEs , MedCity News

Harpoon Therapeutics snags $70 mln Series C

PE HUB

Harpoon Therapeutics raises $45 mln from Arix, New Leaf, others

Funding
PE HUB

VC-backed Harpoon Therapeutics appoints McMahon as president and CEO

Health Strategy Funding